The quantitative brain function imaging device market is projected to reach $9.3B by 2030 at an 8.9% CAGR, driven by multimodal imaging, functional brain mapping, advanced neuro software, psychiatric diagnostics, and portable monitoring systems.
Read More
The pyoderma gangrenosum treatment market is projected to reach $2.12B by 2030 at a 12.1% CAGR, driven by biologic therapies, combination drug regimens, advanced wound care, personalized treatments, and expanded clinical monitoring.
Read More
The protein language models market is projected to reach $3.05B by 2030 at a 25.7% CAGR, driven by AI-driven protein design, cloud modeling platforms, and accelerated drug discovery workflows.
Read More
The prion disease treatment market is projected to reach $4.15B by 2030 at 6.6% CAGR, driven by precision neurology, novel drug discovery, and advanced prion diagnostics.
Read More
The portable biotoxicity detectors market is projected to reach $2.31B by 2030 at 17.5% CAGR, driven by on-field rapid diagnostics, environmental monitoring, and biosensor adoption.
Read More
The polycythemia market is projected to reach $6.53B by 2030 at 7.0% CAGR, driven by JAK2-targeted therapies, personalized treatments, and advanced hematocrit monitoring.
Read More
The plant-derived analgesics market is projected to reach $5.06B by 2030 at 8.4% CAGR, driven by natural therapeutics adoption, cannabinoid growth, and advanced botanical pain therapies.
Read More
The pharmaceutical quality control release testing market is projected to reach $11.01B by 2030 at 7.9% CAGR, driven by biologics growth, regulatory audits, and AI-enabled QC services.
Read More
The personal genome services market is projected to reach $13.69 billion by 2030 at a 14.9% CAGR, driven by preventive genomics, pharmacogenomics, and digital health integration.
Read More
The penicillin API market is projected to reach $12.34 billion by 2030 at a 5.1% CAGR, driven by rising infections, generic antibiotic expansion, and advanced high-purity manufacturing processes.
Read More